. Antibody transcytosis allows efficient whole-mount imaging and spatially controlled lymphocyte activation in the draining LNs. (A) Wholemount imaging of an optically cleared draining LN after s.c. injection of the indicated fluorochrome-conjugated antibodies (10 μg each, t = 30 min, n = 4). Scale bar: 50 μm. (B) Flow cytometric analyses of lymphocyte activation in draining LNs (dLNs) and nondraining LNs (Non-dLNs) after s.c. administration of anti-CD3 and anti-TCR-β antibodies (2 μg each, t = 18 h, n = 3). The cells were stained ex vivo for CD69, CD25, CD4, and CD8. (C and D) Representative CFSE dilution histograms of CD45.2 + OTII donor cells (C) and quantification (D) of OTII lymphocyte proliferation (undivided CFSE hi cells) in the draining and nondraining popliteal LNs after s.c. administration of OVA and control (IgG), agonistic (clone D665), and function-blocking (clone 37.51) CD28 antibodies (n = 3). LPS was used as a positive control. (E-G) The agonistic and function-blocking CD28 antibodies were administered separately to the 2 different legs of the same animal (the same experimental setup as in C), and OTII activation (E and F) and total numbers (G) in the draining LN were measured (n = 5). In the bar graphs, each dot represents 1 LN, and data are the mean ± SD. *P < 0.05 and **P < 0.
Introduction
The lymphatic vasculature controls the clearance of fluid and molecules from all tissues (1) (2) (3) . Endogenous molecules from the periphery as well as exogenous substances penetrating the epithe lial barriers readily gain access to the afferent lymphatic vascula ture. Soluble molecules including antigens, antibodies, chemo kines, and other signaling molecules carried in the interstitial fluid penetrate the extracellular matrix and the buttonlike endothelial junctions of the terminal lymphatic capillaries relatively freely and nonselectively (4, 5) . They then rapidly drain via the afferent lym phatics to the subcapsular sinus of the lymph node (LN).
The subcapsular sinus of the LN is rich in scavenging recep tor-and Fc receptor-expressing macrophages, which capture and destroy many lymphborne molecules (6) . Certain small lymph borne molecules (<70 kDa in molecular mass), on the other hand, can pass through the floor of the subcapsular sinus by traversing narrow transendothelial channels covered with filterlike dia phragms. These molecules then enter adjacent reticular conduits, which distribute them within this cablelike network throughout the LN (7) (8) (9) (10) (11) . In contrast, large (>70 kDa) soluble lymphborne molecules, such as antibodies, cannot enter the reticular conduit system because of physical constraints imposed by the dimen sions of the diaphragms guarding the conduit openings and by the spacing of collagen fibers at the core of the reticular conduits (7, 9, 11, 12) . According to the prevailing concept, large protein anti gens can only gain access to LNs in approximately 10 hours within migratory DCs after proteolytic degradation into small peptides, whereas other types of large biomolecules have no entrance into the LNs (1, 2, (7) (8) (9) (10) (11) .
When studying the function of the subcapsular sinus in LNs, we unexpectedly observed that intact lymphborne IgG antibodies had instant access to the parenchyma of draining LNs in a process independent of reticular conduits. Since antibodies are physiolog ical lymphborne proteins (13, 14) and offer a convenient way of visualizing protein transport in vivo, we used them to dissect the transfer of large lymphborne proteins through the sinus floor. Mechanistically, we show that the transfer takes place through sub capsular sinus lymphatic endothelial cells (LECs) in the fluid phase via an ultrafast dynamindependent transport system. We observed that other exogenous large protein and oligosaccharide antigens were also rapidly transferred to the parenchyma of draining LNs via the same mechanism. This allows the uptake of large antigens in resident LN antigen-presenting cells well before the arrival of the first migratory DCs. We demonstrate that the delivery of intact s.c. injected antibodies to the draining LN via this new transcytosis route can be harnessed to improve the speed (>100fold) and flex ibility of wholemount bioimaging. Therapeutically, we show that the transsinusoidal transfer mechanism allows siteselective, anti bodymediated activation of lymphocytes in a given LN in vivo. We believe these data profoundly alter our knowledge of LN functions and the pharmacokinetics of antibodies.
Results
Rapid transfer of lymph-borne antibodies to the parenchyma of the draining LNs. We originally observed that a lymphborne anti endothelial antibody specifically stained not only the luminal sur face of LECs in the subcapsular sinus of the draining LN but also blood vessel ECs (BECs) deep in the node parenchyma (Supple mental Figure 1A ; supplemental material available online with this Lymph nodes (LNs) filter lymph to mount effective immune responses. Small soluble lymph-borne molecules from the periphery enter the draining LNs via a reticular conduit system. Intact antibodies and other larger molecules, in contrast, are physically unable to enter the conduits, and they are thought to be transported to the LNs only within migratory DCs after proteolytic degradation. Here, we discovered that lymph-borne antibodies and other large biomolecules enter within seconds into the parenchyma of the draining LN in an intact form. Mechanistically, we found that the uptake of large molecules is a receptor-independent, fluid-phase process that takes place by dynamin-dependent vesicular transcytosis through the lymphatic endothelial cells in the subcapsular sinus of the LN. Physiologically, this pathway mediates a very fast transfer of large protein antigens from the periphery to LN-resident DCs and macrophages. We show that exploitation of the transcytosis system allows enhanced whole-organ imaging and spatially controlled lymphocyte activation by s.c. administered antibodies in vivo. Transcytosis through the floor of the subcapsular sinus thus represents what we believe to be a new physiological and targetable mode of lymph filtering.
Transcytosis route mediates rapid delivery of intact antibodies to draining lymph nodes Laura Kähäri, 1, 2 Ruth Fair-Mäkelä, 1, 2 Kaisa Auvinen, 1,2 Pia Rantakari, 1,2 Sirpa Jalkanen, 1, 2 Johanna Ivaska, 3 and Marko Salmi 1, 2 molecules (ref. 6 ; and therefore we did not study the medullary antibody uptake further). When we focused on the cortex, we observed that the lymphborne antibodies penetrated both the extrafollicular areas and the B cell follicles ( Figure 1A) . The anti bodies apparently penetrated the follicles more slowly than they did other areas of the cortex. We found that the lymphborne CD31 antibody rapidly reached the EC plasma membrane in the parenchymal blood vessels in the cortex and paracortex ( Figure  1B) . Ex vivo overlay stainings with a different CD31 antibody con firmed that the binding of the lymphborne antiCD31 antibody was specific (Supplemental Figure 1B) . Flow cytometric quantifi cations showed that the lymphborne B220 and CD4 antibodies had stained a substantial portion of the total B and T cells, respec article; https://doi.org/10.1172/JCI125740DS1). We then admin istered 4 differently tagged monoclonal antibodies (Pacific Blueconjugated antiB220 to detect B lymphocytes; FITCconjugated antiCD4 to detect Th lymphocytes; Alexa Fluor 647-conjugated antiCD11c to detect DCs, and Alexa Fluor 549-conjugated anti CD31 to detect ECs) into the hind paws of WT mice ( Figure 1A ). When the draining popliteal LN was analyzed by microscopy 5 minutes later, we found that all 4 in vivo-administered antibodies had entered the parenchyma and specifically stained their intran odal target cell types in the cortex and paracortex ( Figure 1A ). In addition, all antibodies accumulated nonselectively in the LN medulla, which is known to harbor intraluminal medullary sinus macrophages active in scavenging many types of lymphborne . The luminal surfaces of vessels were labeled by i.v. administration of Alexa Fluor 488-PLVAP antibody. Scale bar: 10 μm. (C and D) Flow cytometric analyses of lymphocytes in LNs after s.c. administration of fluorochrome-conjugated B220 and CD4 antibodies (n = 3-5). The cells were stained ex vivo for CD3. (C) Representative flow cytometric plots and the gating strategy. (D) Quantification of the antibody transfer to the draining (ipsilateral popliteal and lumbar) and nondraining (contralateral popliteal, lumbar, and axillary) LNs. Lymphocytes from untouched mice were stained ex vivo for B220, CD4, and CD3. In bar graphs, each dot represents 1 LN, and data are the mean ± SD. *P < 0.05, by Mann-Whitney U test. (Supplemental Figure 2F ). In fact, even 0.5 to 0.1μg doses of the antibody delivered s.c. in this small volume showed dosedepen dent specific reactivity with the target cells (Supplemental Figure  2F ). The antibody transfer took place in all 5 mouse strains studied ( Figure 1 , Supplemental Figure 2G , and data not shown). Thus, we found that s.c. administration of submicrogram quantities of anti bodies led to their transfer into LN parenchyma within seconds. Antibody transfer to the LN parenchyma is isotype dependent. Many of the biological functions of antibodies are dependent on the isotype of the molecule. We found that all tested lymph borne IgG antibodies (raised in mouse or any of the 6 other host species tested, both monoclonal and polyclonal antibodies, IgG1, IgG2a, IgG2b, and IgG2c subtypes, antibodies against any of the 18 tested surface antigens) entered the parenchyma of the draining LNs ( Figure 1A , Supplemental Figure 3 , A-I, and data not shown). IgG antibodies conjugated to any of the 12 tested fluorochromes (including FITC, Alexa Fluor, APC, PE, Pacific Blue, Brilliant Vio let, eFluor, DyLight, and tandem conjugates), biotin, or HRP, as well as unconjugated antibodies were taken up in the LN ( Figure  1A , Supplemental Figure 3 , A-I, and data not shown), indicating that the transfer through the sinus floor was not induced by any particular fluorochrome. Notably, since the molecular mass of a PEconjugated IgG molecule is close to 400 kDa, these experi ments also revealed that relatively large molecules could be quick ly transferred to the LN parenchyma (Supplemental Figure 3I ). In sharp contrast, we observed that lymphborne IgM antibodies were completely excluded from the parenchyma (Figure 2 , C and D, and Supplemental Figure 3J ), although they did gain access to the sinus (data not shown). Collectively, these data indicate that antibody binding to any sinusoidal cell type and antibody specificity in gen eral are not decisive events in the uptake process and that the trans tively, in the draining LN ( Figure 1 , C and D). Notably, the more central draining LNs (lumbar nodes; i.e., those along the LN chain further away from the s.c. injection site) showed only minimal antibody uptake, and all nondraining LNs (e.g., axillary nodes, contralateral popliteal LN) were devoid of the s.c. delivered anti bodies ( Figure 1 , C and D). The lymphborne antibodies bound to their target antigens only in the first draining LN also after pro longed durations of in vivo distribution (up to 24 hours; Supple mental Figure 1C ). Thus, lymphborne antibodies are transferred through the subcapsular sinus floor to the parenchyma of the pri mary draining LN in a functionally intact form.
The uptake of lymphborne antibodies into the parenchyma of the draining LN was a concentrationdependent process ( Fig  ure 2A and Supplemental Figure 1D ). It was clearly detectable when 1-10 μg antibody was administered s.c. (and faintly with a 0.1μg dose). The transfer was extremely fast, since parenchy mal staining by the lymphborne antibodies was detectable even when the recipient mouse was sacrificed immediately after the injection ( Figure 2B and Supplemental Figure 1E ). When the same antibody pool was given i.v. (at 1 to 50μg doses), intravascular cells were labeled, but no staining was detectable in parenchy mal cells outside the blood vessels (Supplemental Figure 2 , A-C), indicating that BECs are unable to transfer antibodies through the vessel wall. The intranodal staining in the draining LN by the lymphborne antibodies was not due to a possible leakage of free lymphborne antibodies from the sinus during tissue processing, since untouched congenic lymphocytes added to the ex vivo-pro cessing steps remained virtually unstained (Supplemental Figure  2 , D and E). Moreover, antibodies delivered in a 1μl volume (2μg dose) were taken up very effectively to the parenchyma, imply ing that the injection pressure load was not affecting the transfer in the supplemental material). Moreover, lymphborne IgA mole cules were taken up in the draining LNs (Supplemental Figure 4E ). Notably, lymphborne chicken IgY, which does not bind to any mammalian Fc or complement receptor (18) , was also transferred effectively to the parenchyma ( Figure 3C ). These data indicate that the antibody transfer through the sinusoidal floor was inde pendent of Fc and complement receptors.
To study the possible non-Fc receptor-dependent functions of the Fc tail in the antibody transfer, we compared the uptake of whole IgG and (Fab) 2 fragments in the draining LNs. The (Fab) 2 fragment entered the node parenchyma as efficiently as the fulllength antibody (although the staining intensity was fainter because of the lower reactivity of the secondary antibody with the Fc tailless antibody) ( Figure 3D and Supplemental Figure 4F ). Another (Fab) 2 fragment and a Fab antibody were also transferred across the sinus when administered s.c. (Supplemental Figure  4 , G and H). Finally, to study whether the transfer is a receptor dependent process in the first place, we coadministered a 100fold excess of an unlabeled polyclonal mouse Ig or unlabeled mono fer through the sinus floor readily takes place for monomeric IgG molecules and antibody conjugates but not for the pentameric IgM.
Antibody transfer through the sinus floor is a receptor-independent process. To identify the molecules carrying lymphborne anti bodies across the subcapsular sinus in LNs, we first focused on the neonatal Fc receptor (FcRn, also known as Fcgrt), which mediates the transfer of IgG, but not IgM, through the placenta and neonatal gut epithelium (15) . Although Fcgrt mRNA was highly expressed in LECs in peripheral LNs, the transfer of s.c. administered antibod ies was completely intact in FcRndeficient (FcRn -/-) mice ( Figure  3 , A and B, and Supplemental Figure 4A ). FcRIIb (also known as Fcgr2b), expressed at low levels in LN LECs ( Figure 3A ) was not involved in the antibody transfer either, since a functionblocking antibody against this Fc receptor (16) did not interfere with the transfer process (Supplemental Figure 4B ). Deglycosylation of the IgG Fc tail by PNGase F treatment from all Nlinked oligosaccha rides, which regulate FcR and complement binding (17) , did not affect the parenchymal transfer of lymphborne antibodies (Sup plemental Figure 4 , C and D, and see the complete, unedited blots which is not affected by binding to any antigen in the LN. After s.c. administration of the free antibody, we fixed the draining LN by in situ treatment with paraformaldehyde and then visualized the distribution of the free lymphborne antibody by adding a labeled secondary antibody ex vivo onto the tissue sections. We found that the free antibody localized to the cells of the sinus floor ( Figure  4 , A and B). In addition, the free antibody displayed a clear cen trifugal concentration gradient in the node parenchyma, with the highest levels detected immediately below the sinus floor ( Figure  4 , C and D). Moreover, the free antibody apparently surrounded parenchymal lymphocytes in the cortical area of the draining LN clonal antibody with the labeled antibodies. Strikingly, the trans fer of the indicator antibodies to the LN parenchyma remained completely intact in these competition experiments ( Figure 3E and Supplemental Figure 4I ). Thus, the noncompetitive, receptor independent nature of the antibody uptake into the LN parenchy ma is indicative of a fluidphase process. Fluid-phase transfer of antibodies and other large biomolecules through the subcapsular sinus floor. To further address the molec ular mechanisms of the antibody transfer to the LN parenchyma, we used a nonbinding unconjugated rat IgG2a isotype control antibody (hereafter referred to as free antibody), the transit of ( Figure 4 , A and C). These findings would be compatible with the presence of the transferred free antibody in the interstitial flu id and thus strongly argue for the fluidphase nature of antibody transfer through the sinus floor.
Given that a fluidphase transfer should not discriminate between antibodies and other soluble molecules of a similar size, we evaluated the movement of lymphborne dextrans to the LN paren chyma. Fluorescently tagged 70kDa dextran, which does not pen etrate into the reticular conduits (7, 11), was also found intranodally after s.c. administration ( Figure 4E ). Moreover, upon s.c. injections, even a 500kDa dextran was readily visible in the LN parenchyma surrounding lymphocytes ( Figure 4E ). In quantitative analyses, both 70kDa and 500kDa dextrans also showed centrifugal concentra tion gradients in the parenchyma of draining LNs ( Figure 4F ). Col lectively, these data suggest that after transfer across the subcapsu lar sinus floor, the lymphborne antibodies and other biomolecules spread intranodally by convection in the interstitial fluid.
The parenchymal entry of lymph-borne antibodies is an extraconduit and macrophage-independent process. The 2 known path ways mediating delivery of intact molecules to the parenchyma of draining LNs are reticular conduits and subcapsular sinus macro phages. The reticular conduit system only allows the parenchymal entry of soluble lymphborne molecules smaller than 70 kDa in size (7) (8) (9) (10) (11) . However, we observed that the lymphborne free anti body was apparently concentrated along the reticular conduit net work and blood vessels in the paraformaldehydefixed draining LN ( Figure 5A ). The conduits have an inner core composed of col lagen I fibrils surrounded by concentric layers of a microfibrillar zone, basement membrane, and an outer wrapping of fibroblastic reticular cells (Refs. 9, 10, 12, and Figure 5B ). Quantitative analy ses revealed apparent colocalization of the free antibody with the microfibrillar zone marker ER-TR7 and the fibroblastic reticular cell marker smooth muscle actin (SMA) ( Figure 5C ). However, the free antibody apparently did not colocalize with the inner core marker collagen I ( Figure 5C ). To address the potential entry of antibodies into conduits using a functional assay, we injected the ER-TR7 and collagen I antibodies s.c. into mice. We reasoned that if antibodies entered the conduits, they should stain the internal conduit structures. On the other hand, if the antibodies entered the parenchyma outside the conduits, they should not be able to bind to the inner components of the conduits, which are tightly ensheathed by the fibroblastic reticular cells and basement mem branes (19, 20) . When we analyzed nonfixed LNs after the s.c. injections of these 2 antibodies, we found no reactivity with the conduits ( Figure 5D ). Importantly, in control experiments, the same antibodies reacted strongly with the conduits when direct ly applied to the sections ex vivo ( Figure 5E ). These data suggest that the transcytosed free antibody was apposed to but not with in the conduits. The free antibody was also concentrated around the ER-TR7 + basal aspects of high endothelial venules ( Figure 5A ). Collectively, these findings indicate that after lymphborne anti bodies have been transferred through the sinus floor, they move freely around the cellular constituents and matrix barriers in the parenchyma of the draining LNs.
Readymade immunocomplexes have been reported to enter the LN parenchyma by propelling on the surface of subcapsular sinus macrophages (21, 22) . To analyze the potential role of sub capsular sinus macrophages in the transfer of antibodies through the sinus floor, we locally depleted this cell type by injecting clo dronate into the calf of recipient mice ( Figure 6A ). This treatment protocol leaves the footpad intact for subsequent injections (23) . CD169 staining verified an effective depletion of subcapsular sinus macrophages in the draining popliteal LNs of clodronatetreated legs, whereas these cells remained intact in the vehicletreated legs ( Figure 6B ). Notably, the absence of subcapsular sinus mac rophages did not affect the parenchymal transfer of lymphborne B220, CD11c, or CD31 antibodies in any way ( Figure 6B ). Thus, the extraconduit and macrophageindependent nature of anti body transfer through the sinus floor is strongly indicative of a new mode of lymph filtration.
Transcytosis of lymph-borne antibodies through subcapsular sinus LECs. The floor of the subcapsular sinus is mainly composed of LECs interspersed with subcapsular sinus macrophages (refs. 1, 11, 24, and Supplemental Figure 5 , A and B). Since macrophages were not involved in the antibody transfer, we next focused on the potential role of LECs in the uptake of antibodies. Certain macro molecules can be shuttled from one surface of the cell to the other by transcellular vesicular transport, i.e., transcytosis (15, (25) (26) (27) (28) (29) (30) . We found that the extremely attenuated (often <200 nm in thick ness) cytoplasmic projections of sinusoidal LECs are very rich in heterogeneous cytoplasmic vesicles resembling flaskshaped cav eolae, round intracytoplasmic vesicles, and elongated tubulovacu olar structures ( Figure 7A ). Immunoelectron microscopy revealed that the lymphborne free antibody localized to heterogeneous vesicular and tubular structures in the LECs of the sinus floor ( Fig  ure 7 , B-D, and Supplemental Figure 5 , C-E). The antibody did not induce the formation of any macropinocytic vesicles (Figure 7 Figure 7E ).
To investigate the endosomal nature of the free antibodycontaining vesicles, we performed Airyscan highresolution con focal imaging of EEA1 + vesicles (a marker of early endosomes; ref. 31 ) in the subcapsular sinus floor. When focusing on CD31 + floor LECs, we found multiple clearly identifiable EEA1 + early . Among nonclathrinmediated endocytic processes, macropi nocytosis mediates the uptake of nutrients and extracellular flu id into cells (35) . However, neither EIPA, an amiloride derivative inhibiting Na + /H + exchange needed for macropinosome matura tion (36) , nor imipramine, a newly identified selective inhibitor of macropinocytosis (37) , interfered with antibody transfer (Figure 8 , E and F, and Supplemental Figure 6 , E-H). Since many endocytosis routes are dynamin dependent, we tested the effect of dynamin inhibitors on the transfer of anti bodies. Microscopy revealed that in Dyngo4a-treated (38) LNs, lymphborne B220 and CD31 antibodies did not penetrate as deeply into the parenchyma below the sinus and did not stain the cells as brightly as in the vehicletreated controls ( Figure 9A ). Flow cytometric quantifications showed that the Dyngo4a treatment inhibited approximately 70% of the antibody transfer and verified the lower staining intensity of the remaining cells ( Figure 9B and Supplemental Figure 6I ). Importantly, when using the local Dyngo 4a application, delivery of the lymphborne antibodies up to the subcapsular sinus remained intact, as revealed by sinusoidal EC staining by the CD31 antibody ( Figure 9A ). The use of another structurally distinct dynamin inhibitor, Dynole 34-2 (39), and its specific negative control compound, Dynole 31-2, confirmed the endosomes (Supplemental Figure 5F ) and observed that the free antibody was localized within or in contact with a number of EEA1 + endosomes ( Figure 7F and Supplemental Video 1) and was enriched in EEA1 + volumes when compared with EEA1 − volumes within the LECs. Collectively, the immunoelectron microscopy and confocal imaging data indicate that antibody transfer from lymph to the parenchyma of the draining LN occurs via transcyto sis through sinusoidal LECs.
To mechanistically study the endocytosis and transcytosis of antibodies in the floor LECs, we functionally interfered with these pathways using chemical inhibitors and, when available, genedeficient mice. Transcytosis in BECs is largely mediated by caveolae (15, (26) (27) (28) (29) . We therefore studied antibody transcytosis in caveolin1-deficient mice (Cav1 -/mice), which lack all caveolae and hence caveolindependent endocytosis and transcytosis (32) . However, we found that the transcytosis of lymphborne antibod ies was completely intact in the absence of caveolae ( Figure 8A) . To dissect the role of other endocytic pathways in the antibody transfer, we topically applied selective endocytosis inhibitors directly to surgically exposed draining LNs, leaving the footpad lymphatics unperturbed for s.c. antibody injections ( Figure 8B ). One leg of the mouse was always used for the inhibitor treatment and the other leg for the control treatment. We first focused on the major clathrinmediated endocytosis pathway. Pitstop 2, a cellpermeable smallmolecule inhibitor blocking ligand binding to the clathrin terminal domain (33), did not significantly inhib it transcytosis of CD4 or B220 antibodies when compared with a processed by the local resident antigenpresenting cells. To exper imentally test this, we s.c. administered a fluorescently tagged exogenous 180kDa protein antigen (Alexa Fluor 647-labeled human AOC3 protein) and followed its uptake into the resident LN DCs and macrophages. We found that more than 15% of tis sueresident DCs (CD45 + CD3 − CD19 − CD11c hi MHC II + cells) (41) had ingested the antigen after 2 hours ( Figure 10 , A-C). As expect ed, the large protein antigen was also found in subcapsular sinus macrophages (CD45 + CD3 − CD19 − CD11c − CD11b + F4/80 − CD169 + cells) and medullary sinus macrophages (CD45 + CD3 − CD19 − CD11c − CD11b + F4/80 + CD169 + cells), which are in direct contact with the lymph in the sinus ( Figure 10 , A and D). Importantly, many LN parenchyma-resident macrophages (CD45 + CD3 − CD19 − CD11c − CD11b + F4/80 + CD169 − cells) (6) , which are not in contact with the sinus, had also taken up the s.c. delivered protein antigen within 2 hours ( Figure 10, A and D) . Collectively, these data show that large lymphborne protein antigens from the periphery are transcytosed to the LN parenchyma and rapidly presented to the immune system well before the arrival of migratory DCs.
dynamin dependence of the antibody transfer across the LN sinus ( Figure 9C and Supplemental Figure 6J ). Finally, we found that paracellular permeability was not likely to regulate the antibody transfer, since adrenomedullin, which stabilizes lymphatic endo thelial junctions (40) , had no detectable effect on the antibody transfer ( Figure 8G and Supplemental Figure 6 , K and L). Our imaging and functional data, thus, collectively indicate that the fluidphase pinocytotic transcytosis of antibodies across the sinus is largely mediated by dynamindependent endocytosis and trans fer in endomembranes and tubulovesicular structures of LECs.
Rapid ingestion of transcytosed large protein antigens by resident antigen-presenting cells in the LNs.
Given their inability to enter the reticular conduits, large protein antigens from the periphery are thought to gain entrance into the parenchyma of the draining LNs only within migratory DCs (1, 2, 7-11). The uptake of antigens and DC activation and migration to the draining LN takes approxi mately 10 hours. We reasoned that the fluidphase transcytosis pathway through the LECs of the sinus floor should deliver in sec onds any large protein antigen to the draining LN, where it can be suffer from loss of antigenic epitopes, poor performance of directly conjugated antibodies, and long staining times (typically 4 days) required for the penetration of antibod ies into permeabilized tissues in vitro (42) (43) (44) (45) (46) . We found that 30 minutes of in vivo staining with a pool of differ ent fluorochromelabeled antibodies followed by a short clearing allowed efficient 3D visualization of parenchy mal cells in the draining LN when the staining antibodies were delivered in vivo by s.c. administration ( Figure 11A and Supplemental Video 2). These analyses also confirmed that convection of antibodies into the B cell follicles was slower than that into the interfollicular stroma. Moreover, antibodies, which are exquisitely sensitive to target epi tope destruction by any type of tissue processing, worked unperturbed in immunohistochemistry when allowed to be transferred in vivo into an intact draining LN through the sinus floor (Supplemental Figure 7, A and B) . Thus, applica tion of parenchymal transfer of lymphborne antibodies for wholemount imaging allows for singlestep staining with pools of fluorochromeconjugated antibodies combined with a more than 100fold shortening of the staining time compared with current protocols.
Local control of immune responses by the transfer of lymphborne antibodies in vivo.
Finally, we evaluated the potential of the parenchymal transfer of lymphborne antibodies in con trolling local immune activation. T cell activation in vitro is routinely done by using a combination of platebound ago nistic antibodies against the T cell receptor and CD3. We injected 2 μg of these antibodies s.c. and found that they remained local in the draining LN throughout the duration of the experiment (Supplemental Figure 7 , C and D). When the antibodytriggered induction of early T cell activation was analyzed after 18 hours, we found very efficient upregu lation of CD69 and CD25 on the CD4 + and CD8 + T lympho cytes in the draining LNs, but not in the nondraining LNs ( Figure 11B ). Control antibodies did not trigger any lympho cyte activation (Supplemental Figure 7E) .
Lymphocyte proliferation was also locally inducible when we used lymphborne antibodies against immune checkpoint molecules. We transferred naive CFSElabeled OVAspecific transgenic T lymphocytes (OTII cells) into WT recipient mice and allowed the cells to home to LNs. The next day, OVA was injected, and control and checkpointmodulating anti bodies were injected together with OVA and on the following 2 days. When analyzed on day 4, we found that OVA and the control antibody induced modest proliferation (measured by CFSE dilu tion) of the transferred OTII cells in the draining LNs (Figure 11 ,
Improved bioimaging by application of parenchymal transfer of lymph-borne antibodies.
After showing physiological relevance of the transfer of large lymphborne proteins through the subcap sular sinus floor, we wanted to test whether this route could be harnessed for other purposes as well. Wholemount imaging of optically cleared organs has been instrumental in dissecting the functional anatomy of tissues. However, the current techniques sis pathway through sinusoidal LECs. We also show that in vivo antibody uptake through the sinusoidal floor can be utilized to improve bioimaging and for local modulation of immune respons es in draining LNs. Two main mechanisms mediating protein transfer across the subcapsular sinus in the draining LN have been described. Soluble lymphborne molecules with a hydrodynamic radius of less than 5 to 6 nm (<70kDa globular proteins) enter the LN parenchyma via the reticular conduit network, which excludes all larger mol ecules (7) (8) (9) (10) (11) . On the other hand, readymade immunocomplex es are selectively delivered to follicular B cells in a complement receptor-dependent manner by subcapsular sinus macrophages (21, 22) . The transcytosis process we have identified here is completely different from these 2 previously described transport mechanisms. The newly described process involves the transfer of molecules of up to 500 kDa for free percolation and convection in the intersti tial fluid outside the reticular conduits; it is perfectly intact in mice after depletion of subcapsular sinus macrophages; it is a receptor independent, fluidphase process; and it takes place through sinu soidal/subcapsular sinus LECs (Supplemental Figure 8) . The entry of s.c. administered antibodies into the draining LN was observed earlier in a few experiments using sophisticated immu nization pro tocols and adoptive transfer of lymphocytes, high doses (20-25 μg) C and D). Coinjection of the agonistic costimulatory antiCD28 antibody D665 (47) with OVA triggered vigorous cell division in the draining LNs, but not in nondraining LNs (Figure 11 , C and D). When the agonistic (D665) (48) CD28 antibody was s.c. admin istered to the left footpad and the antagonistic (37.51) (49) CD28 antibody was injected into the right footpad of the same animal, we found robust lymphocyte proliferation in the left draining LN when compared with the right draining LN (Figure 11 , E-G). Thus, local delivery of s.c. administered antibodies through the sinus floor allows functional manipulation of lymphocyte activation in a spatially controlled manner in vivo.
Discussion
Here, we have identified a transcytosis mechanism for lymph fil tering in draining LNs. We show that large, intact lymphborne biomolecules, including s.c. administered antibodies, are trans ferred across the subcapsular sinus floor to the parenchyma of the draining LN in seconds. We believe this profoundly alters the current dogma that large (>70 kDa) foreign antigens from the periphery only gain entrance into the LN parenchyma approxi mately 10 hours after proteolysis within migratory DCs. We found that parenchymal transfer of large biomolecules takes place via a previously unknown fluidphase, dynamindependent transcyto ma of the draining LN, where they can execute any of their multi ple effector and signaling functions.
We discovered that the large lymphborne molecules traverse the subcapsular sinus lining LECs by fluidphase transcytosis (Supplemental Figure 8) . We observed that the s.c. administered nonbinding antibody transits via intracellular vesicles in LECs using both immunoelectron microscopy and confocal imaging of EEA1 + early endosomes. Antibody entry via the paracellular route is unlikely, since we observed no antibody signal at the inter endothelial junctions with any of the imaging techniques, and tightening of the endothelial junctions with adrenomedullin did not inhibit the transfer. Different types of endocytotic processes display characteristic ligand dependency, vesicular morpholo gy, and molecular machinery (56) (57) (58) (59) . The dynamin dependence of the transfer of lymphborne cargo through sinusoidal LECs would have been compatible with the possibility that either mac ropinocytosis or caveolae or clathrinmediated endocytosis was involved and argued against the role for dynaminindependent forms of the endocytosis. However, we did not observe, either by immunoelectron or confocal microscopy, any formation of macropinocytic vesicles during the transfer, and the process was insensitive to 2 different inhibitors of macropinocytosis. Further more, we observed normal antibody transfer in the Cav1 −/− mice (32) , excluding the role of caveolaedependent endocytosis and transcytosis in the process. Clathrinmediated endocytosis, on the other hand, is typically triggered by receptor ligation and only involves small volumes of passive fluid transport, takes place via regularly shaped round vesicles, and is a relatively slow process that requires approximately 2 minutes in every cell type studied (57) . Our findings showing that antibody transcytosis is receptor independent, takes place in elongated tubulovesicular organelles, and has extremely fast kinetics (<30 s from the s.c. injection) are not compatible with a clathrindependent process. Moreover, 2 structurally distinct clathrin inhibitors did not interfere with the antibody transfer. We therefore believe that the majority of anti body transfer through the sinus floor takes place independently of macropinocytosis and caveolae and clathrin vesicles, although we do not imply that antibodies would be specifically excluded from the fluid volume entering these types of vesicles if their formation is triggered by other ligands. Although the analyses of endocytosis under in vivo settings in LNs remain technically and methodolog ically challenging, we find it interesting that the transfer process through the sinus floor has apparent similarities to fast and ultra fast forms of endocytosis, which have so far been identified only in synaptic terminals (56, 58, 59) .
The transcytosis pathway identified here can be harnessed for several purposes. We believe it opens new possibilities for bio imaging by allowing very fast in vivo labeling of parenchymal LN cells in situ using pools of s.c. administered fluorochromecon jugated antibodies. In addition, this pathway allows the precise manipulation of immune responses by antibodies in a given LN in a spatially highly localized manner. Therefore, it could be poten tially exploited to develop new, thoroughly characterized anti bodybased adjuvants for vaccines. The parenchymal uptake of lymphborne antibodies could be useful for delivering checkpoint inhibitors or tumor cell-depleting antibodies to the tumor drain ing LNs. When compared with systemic treatments, this approach of anti-follicular DC antibodies, and extensive redistribution dura tions (24-48 hours), but the pathways involved were not analyzed (50, 51) . Our current analyses demonstrate the transcytotic anti body transfer to multiple targets on the draining LN using antibody doses that were more than 200foldlower and distribution times that were more than 2800fold shorter under strictly physiolog ical conditions. In conjunction with elegant realtime analyses of conduit filling, it has also been reported that large foreign proteins are found in the subsinusoidal interstitial space of the draining LN after 6 minutes, but the route or mechanism of the transfer was not elucidated in any way (10, 52) . Our analyses thus reveal that vesic ular fluidphase transfer through LECs into the subcapsular sinus represents a third major pathway for protein transfer into the stro ma of the draining LN (Supplemental Figure 8) .
Interestingly, the uptake of s.c. injected antibodies and dex trans of 70 kDa or more in the LN parenchyma was not reported in the elegant landmark study by Gretz et al., which evaluated lymph filtration by microscopy (7) . We speculate that when they visual ized the high local concentrations of the labeled molecules in the narrow subcapsular sinus and reticular conduits, dextrans diffus ing throughout the parenchymal interstitium may have remained below the detection threshold, as was, in fact, the case in our own previous analyses (11) . Moreover, Gretz et al. used a single anti-MHC I antibody, a large fraction of which will bind already in the skin and lymphatic vessels to MHC I expressed at high levels on all nucleated cells, which possibly hampered its detectability in the microscopic studies of the LN parenchyma. Using the same anti-MHC I antibody clone, conjugate, and dose, we demonstrate by flow cytometric and microscopic analyses that this antibody is also transferred to the parenchyma of draining LNs (Supplemental Figure 3, A and B) . Collectively, our analyses with 2 highmolecu larweight dextrans, a 180kDa nonantibody protein antigen, and almost 40 different antibodies clearly show the robust transfer of large lymphborne proteins and polysaccharides through the sub capsular sinus floor to the parenchyma of draining LNs.
The transfer of lymphborne antibodies to the draining LN is immunologically relevant under both physiological and patholog ical conditions. IgG is one of the most abundant proteins in the interstitial fluid of healthy skin (concentration of ~5 μg/μl) and in the lymph proteome (13, 14) . Under steadystate conditions, IgG concentrations in the afferent lymph reach approximately 20% of those measured in plasma (i.e., lymph concentration of ~5 μg/μl) and are even higher in the efferent lymph also containing the Ig produced locally in the LN (53) . In inflammation, the amount of Ig in the interstitial fluid and lymph further increases as a result of the changes in capillary walls, which allow paracellular leak age of plasma Ig into the extravascular tissues and extravasation of Igproducing plasma cells into sites of inflammation (13, 54, 55) . In addition, very high levels of antibodies are introduced to the skin in clinical settings when therapeutic antibodies such as trastuzumab (antiHER2), adalimumab (antiTNF), denosumab (antiRANKL), and ustekinumab (anti-IL-12 and anti-IL-23) are administered s.c. for systemic delivery. The antibody concentra tion in these injections is typically approximately 100 μg/μl. Thus, the transcytosis mechanism identified here will instantly deliver intact endogenous and exogenous monomeric antibodies from the periphery through the subcapsular sinus floor to the parenchy jci.org Volume 129 Number 8 August 2019
Alexa Fluor 488-conjugated anti-PLVAP antibody was injected i.v. (to stain the luminal surface of BEC), and the mice were sacrificed 3 minutes later.
Processing of the LNs for microscopy. The isolated LNs were care fully embedded in a predetermined orientation (to produce vertical sections in relation to hilar blood vessels) in OCT medium under a stereomicroscope. The samples were snapfrozen on dry ice, stored at -70°C, and used for the cutting of 6μm cryostat sections. When fluorochromeconjugated antibodies that bind to mouse antigens had been injected s.c., the sections were overlaid with ProLong Gold mounting medium (Thermo Fisher Scientific) without any ex vivo fix ations or ex vivo stainings. When indicated (ex vivo staining), the sec tions were stained in vitro for additional markers.
When the unlabeled free antibody (rat IgG2a isotope control, 553926, BD) was used, an in situ fixation step was included. Thirty sec onds after s.c. injections of the free antibody, 4% paraformaldehyde solution was injected s.c. After 90 seconds, the mice were sacrificed, LNs isolated, and cryosections cut. Before stainings, the sections were further fixed with icecold 4% paraformaldehyde for 5 minutes at 4°C. The sections were then washed with PBS, quenched with 0.1 M gly cine, and washed with PBS. The s.c. injected free antibody was visu alized by ex vivo staining of the sections with a speciesspecific Alexa Fluor 488-conjugated anti-rat IgG antibody. When indicated, other marker antibodies were added to the sections after washings.
The LNs from mice injected s.c. with lysinefixable dextrans were fixed with paraformaldehyde in situ and ex vivo, as described above. Popliteal LNs from untouched mice were fixed and processed identi cally to serve as controls.
For EEA1 stainings, the frozen sections were fixed (4% paraformal dehyde), quenched (50 mM NaH 4 Cl), blocked (30% horse serum), and permeabilized (0.3% Triton X). The sections were incubated with an antiEEA1 antibody overnight at +4°C followed by an anti-rabbit Alexa Fluor 546 secondary antibody. Finally, CD31 was used to stain for sub capsular sinus LECs, and DAPI was added for nuclear detection.
Confocal microscopy and image analyses. The immunofluorescent ly stained sections were examined using an LSM 780 confocal micro scope (Carl Zeiss) with PlanApochromat 20×/0.8 and cApochromat Korr M27 40×/1.20 objectives and Zen 2010 software (Carl Zeiss). Pinhole adjustments were used to produce the same slice thickness (typically 1.2μm thickness) for each channel.
Image analyses were performed using ImageJ software (NIH). The background was subtracted from all images (except Figure 8A) , and linear brightness adjustments were made in certain cases. Bright ness adjustments and thresholds were always applied equally to all images used in comparisons. Quantifications of staining intensities for the free antibody and dextrans in LN zones 1-6 (zone 1 corresponds to the subcapsular sinus and zone 6 to the deep paracortical area) were done by measuring the MFI of regions of interest using ImageJ soft ware. The staining intensities along reference lines across the conduits were measured using the ImageJ plugin RGB Profiler. In these exper iments, the core of the conduits was defined by maximal collagen I staining and the outer surfaces of the conduits by the peaks of ER-TR7 staining intensities. For certain representative images, maximal pro jections were generated from Zstacks, and noise was reduced using the mean filter function in ImageJ. EEA1 + vesicular structures were imaged using an LSM 880 confo cal microscope (Carl Zeiss) with an Airyscan detector (Carl Zeiss) and would have clear dosesparing and precision targeting potential, since the lymphatic drainage will carry peri or intratumorally injected therapeutic antibodies by default to the same LNs, which drain the metastatic cells escaping from the primary tumor.
In conclusion, we have discovered what we believe to be a con stitutively active, mechanistically novel mode of lymph filtering by LECs in LNs that allows extremely efficient fluidphase transcyto sis of any large biomolecule (<500 kDa) through the sinus floor to the parenchyma of draining LNs in an intact form within seconds. Targeted delivery of s.c. administered antibodies selectively to the draining LN opens new avenues for harnessing the filtering func tions of LNs for immune modulation.
Methods
Mice. WT C57BL6/J, C57BL6/N, SJL, and BALB/c mice were pur chased from Charles River Laboratories and Janvier Labs. Cav1 tm1Mls/J (Cav1 -/-, stock 004585) (32) , FcRn −/− (60), and OTII (expressing trans genic αβ T cell receptors [TCRs] that are specific for chicken OVA) (61) mice were obtained from The Jackson Laboratory. Six to ten weekold mice of both sexes (age and sexmatched animals within each experiment) were used.
Antibodies. The antibodies used in this study are listed in Supple mental Table 1 . (Fab) 2 fragmentation of MEL-14 and 9-11 antibodies was customgenerated by GenScript. When indicated, antibodies were biotinylated using Nhydroxysuccinimide ester (NHS) bio tin, conjugated to HRP using the HRP Conjugation Kit (ab102890, Abcam), or treated with PNGase F using the Rapid PNGase F Diges tion Kit (nonreducing format; New England BioLabs).
Subcutaneous administration of antibodies and dextrans. The anti bodies were filtered using a 10kDa cutoff centrifugal filter unit (MRCPRT010, MilliporeSigma) to remove any possible free fluoro chromes and, when necessary, to concentrate the antibodies. The recip ient mice were slightly anesthetized using isoflurane, and the antibod ies were injected s.c. into the dorsal aspect of hind paws in 10 to 20 μl volume using Microfine Demi 0.3ml syringes (BD) and a 30-G needle, unless otherwise indicated. The dose and in vivo distribution time of the s.c. injected antibodies are specified in the text and figure legends.
TRITCconjugated, lysinefixable 70kDa dextran (D1818, Invit rogen, Thermo Fisher Scientific) and FITCconjugated, lysinefixable 500kDa dextran (D7136, Invitrogen, Thermo Fisher Scientific) were injected s.c. (50 μg/paw).
At the end of the experiments, the mice were sacrificed (cervi cal dislocation for short distribution time points and carbon dioxide asphyxia for longer ones), and the draining LNs (ipsilateral popliteal), the second LN in the chain (lumbar), and nondraining LNs (axillary and contralateral popliteal LNs) were rapidly dissected free ( Figure  1A) . We verified the lymphatic drainage pathway from the skin by s.c. Evans blue dye injections (data not shown). The time interval between cervical dislocation and freezing of the draining popliteal LN was less than 30 seconds.
Intravenous administration of antibodies. When indicated, Pacif ic Blue-conjugated antiB220, FITCconjugated antiCD4, Alexa Fluor 647-conjugated antiCD11c, and Alexa Fluor 594-conjugated antiCD31 (1 to 50μg doses) were injected i.v. into the tail vein and allowed to circulate for 10 minutes.
For detection of BECs, Alexa Fluor 594-conjugated antiCD31 antibody was administered via the s.c. route. After 2 minutes, 30 g jci.org
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indicated, fluorochromeconjugated antibodies against other leukocyte surface markers were added during the ex vivo processing steps. Before ex vivo stainings, the samples were treated with Fc block and stained with Fixable Viability Dye eFluor 780 (eBioscience). The cells were analyzed using a BD LSRFortessa flow cytome ter. For comparisons between different groups, the data were always acquired using identical instrument settings. All flow cytometric data were analyzed using Flow Jo software (TreeStar).
In selected experiments, CD45.2 + mice were injected s.c. with the antibody pool. After collecting the draining popliteal LN, it was pooled into the same tube with an untouched popliteal LN isolated from an uninjected CD45.1 + mouse. The lymphocyte suspension was then made, and the binding of s.c. administered antibodies on CD45.1 + and CD45.2 + cells was separately analyzed by flow cytometry.
Competition experiments. The function of the Fc receptors CD16 and CD32 in the antibody transfer was analyzed by s.c. injection of a func tionblocking antibody (2.4G2, Fc block; ref. 16) or vehicle alone. After 5 minutes, a second dose of Fc block (or vehicle alone), together with the directly labeled test antibodies, was administered s.c. to the same paw.
For competition experiments with unlabeled Igs, a pool of fluoro chromeconjugated test antibodies was mixed in vitro with a 100fold molar excess of unlabeled rat IgG2a monoclonal antibody (antiCD44 antibody 9B5) or with purified polyclonal mouse Ig, and the mixture was then administered s.c. to mice. Control animals obtained the same pool of fluorochromeconjugated test antibodies diluted in the vehicle (PBS).
In vivo clodronate depletions. To deplete macrophages from the draining LNs, a single injection of clodronate liposomes (or vehicle loaded liposomes as controls) was administered s.c. into the anterolat eral surface of the tibia on day 0 (23). Three days later, the test antibod ies were administered s.c. into the footpad of the same paw.
Treatments with endocytosis inhibitors in vivo. The mice were anes thetized and the popliteal LNs were surgically exposed with mini mal tissue trauma. Different inhibitors were applied directly to the exposed left popliteal LN, and the exposed right popliteal LN was sim ilarly treated with control solutions with approximately 50μl droplets of prewarmed solution. Fresh droplets were instilled at 2 to 3minute intervals for 15 minutes. Thereafter, a pool of fluorochromeconjugat ed antibodies was administered s.c. to both paws and allowed to dis tribute for 5 minutes before the mouse was sacrificed.
The following endocytosis inhibitors and controls were used: clathrin inhibitor Pitstop 2 (33) (Abcam) and its specific negative con trol (Pitstop 2 control, Abcam) both at 75 μM; the clathrin inhibitor monodansylcadaverine (34) (MilliporeSigma; 100 μM) and its DMSO vehicle control; the macropinocytosis inhibitor EIPA (36) [5(Nethyl Nisopropyl amiloride, MilliporeSigma; 100 μM] and its DMSO vehi cle control; the macropinocytosis inhibitor imipramine (37) (Millipore Sigma, 15 μM) and its PBS vehicle control; the dynamin inhibitor Dyngo4a (38) (MilliporeSigma, 400 μM) and its DMSO vehicle control; and the dynamin inhibitor Dynole 34-2 (39 (Abcam) and its specific control Dynole 31-2 (Abcam), both at 75 μM. In addition, we applied adrenomedullin (Phoenix Pharmaceuticals; 100 nM), which stabilizes interendothelial junctions (40) , and its vehicle control (PBS) using the same protocol.
Antigen uptake by resident antigen-presenting cells. Recombinant human AOC3 protein (180kDa MW; Peprotech) was conjugated to Alexa Fluor 647 using a Microscale Protein Labeling Kit (Thermo Fish er Scientific). After filtering, 2 μg protein was injected s.c. into mice. a C PlanApochromat 63×/1.4 oil objective. Images were acquired and processed with Zen 2.3 SP1 FP2 software (Carl Zeiss). Images were taken from a single plane, or Zstacks were imaged from the subcapsu lar sinus with a 0.15μm slice interval from a total thickness of 1.75 to 2.03 μm. Linear brightness adjustments and image analysis were done using Imaris 8.1.2 software (Bitplane). The "Surface" tool was used to create a mask of CD31 + floor LECs, and the "Spots" tool was used to detect vesicular structures formed by the free antibody (0.3μm radi us; distinguished on the basis of signal intensity over a cutoff value set with the negative control). The surface of EEA1 + vesicles was modeled in 3D using the "Surface" tool. The free antibody vesicles and their contact with EEA1 + vesicles were enumerated manually. A video por traying the free antibody and EEA1 vesicles was recorded and convert ed to QuickTime files using Imaris 8.1.2.
A 3i Spinning Disk confocal microscope (Intelligent Imaging Innovations) with an LD cApochromat 40×/1.1 W objective was used to image crosssectional areas of whole LNs. Images were acquired using SlideBook 6 software (Intelligent Imaging Innovations). Back ground subtractions, linear brightness adjustments, and mean filter noise reductions were done using ImageJ software.
Optical clearing and whole-mount imaging. For the wholemount stainings, we injected 10 μg fluorochromelabeled antibodies s.c. and isolated the draining LNs after 30 minutes. The methodology for the optical clearing of wholemount samples with benzyl alcohol and benzyl benzoate (BABB) was adapted from ref. 62 and performed as described previously (11, 63) .
The samples were imaged with an LSM 780 confocal microscope (Carl Zeiss) using a PlanApochromat 20×/0.8 objective and Zen 2010 software. Subtraction of the background and linear brightness adjust ments were performed using Imaris 8.1.2 software. 3D image recon struction was generated from Zstacks (5μm slice thickness) using Imaris 8.1.2 software, and the results were converted to QuickTime files.
Transmission and immunoelectron microscopy. Untouched LNs were collected and processed for transmission electron microscopy as previously described (11) .
For immunoelectron microscopy, the free antibody was admin istered s.c. for 2 minutes. The draining LNs were then perfused with prewarmed PBS (37°C), perfusion fixed (0.01 M periodate, 0.075 M lysine, 0.037 M Na phosphate buffer with 2 % paraformaldehyde and 0.2% glutaraldehyde), collected, immersion fixed in the same buffer for 1 hour at room temperature, and cryoprotected with 2.1 M sucrose overnight at 4°C. The LNs were then extensively washed in a phosphate buffer, snapfrozen, cut into 10μm sections, and stained with 10 nm goldconjugated goat anti-rat IgG (EM.GAT10, BBI Solu tions) in a phosphate buffer containing 0.5 % fish gelatin and 0.5 % BSA for 3 hours at room temperature. After postfixation, dehydration, and embedment on the microscope slides, polymerized blocks were detached, and 70nm sections were cut using an ultramicrotome. Finally, the sections were stained with 1 % uranyl acetate and 0.3 % lead citrate and examined using a JEM-1400 Plus transmission elec tron microscope (JEOL).
Flow cytometry. After collecting the LNs, lymphocytes were mechan ically teased from the tissue and filtered. When fluorochromeconjugat ed primary antibodies were injected in vivo, the suspended cells were subjected to FACS analyses without any further processing. When unconjugated antibodies were administered, the cells were stained ex vivo with Alexa Fluor 488-conjugated secondstage antibodies. When Uninjected mice served as controls in all experiments. After 2 hours, the draining LNs were isolated and used for flow cytometry or snap frozen for immunohistochemical analysis. For flow cytometric analy ses, singlecell suspensions were prepared by digesting minced pieces for 30 minutes at 37°C in a buffer (HBSS) containing collagenase D (1 mg/ml) and DNAse I (50 μg/ml). The cells were then stained ex vivo for CD45, CD3, CD19, CD11b, CD11c, MHC II, F4/80, and CD169 and analyzed using the BD LSRFortessa. For immunohistochemical analy ses, frozen sections were cut and stained ex vivo for CD11c.
Local T cell activation by s.c. administered stimulatory antibodies. AntiTCR (clone H57-597, PerCP Cy5.5conjugated) and anti CD3 (clone 145-2C11, FITCconjugated) antibodies (3 μg each) were administered s.c. into the left hind paw. Isotypematched control anti bodies were similarly injected into control mice. One group of mice was sacrificed after 5 minutes, and the rest of the mice were sacrificed after 18 hours. The draining and nondraining LNs were isolated and stained ex vivo using fluorochromeconjugated antibodies against CD4, CD8, and the early T cell activation markers CD69 and CD25.
In another experimental setup, splenocytes were isolated from CD45.2 + OTII donor mice expressing a transgenic TCR for OVA (61) . Untouched naive CD4 + lymphocytes were enriched from the spleno cytes using a negative MACS Selection Kit (Miltenyi Biotec). The puri fied cells (typically more than 90% of Lselectin hi CD44 lo CD4 + cells) were fluorescently labeled with 1 μM CFSE for 30 minutes at 37°C. The labeled cells were then adoptively transferred into CD45.1 + con genic recipients via i.v. injections (5 × 10 6 cells/mouse) and allowed to redistribute to LNs and other organs for 18 hours. Thereafter, an agonistic antiCD28 antibody (clone D665) (47) , an antagonistic anti CD28 antibody (clone 37.51), or a control antibody together with 2 μg OVA antigen were administered s.c. to the recipient mice. Unlike what is observed in vitro, the clone 37.51 antibody functions as a CD28 antagonist in vivo (48, 49, 64) . Coinjection of OVA and LPS (2 μg, from Escherichia coli O111:B4, MilliporeSigma) as an adjuvant served as a positive control. After 3 days, the draining and nondraining popliteal LNs were isolated. The cells were stained ex vivo for CD45.2, and the dilution of CFSE labels in the transferred cell population was deter mined using flow cytometry. For quantification of cell division, the percentages of the labeled OTII cells in the CFSE hi (undivided) and CFSE lo (divided ≥5 times) cell populations were determined. In certain experiments, the agonistic CD28 antibody was injected into the left hind paw and the antagonistic CD28 antibody into the right hind paw of the same animal. The absolute numbers of OTII T cells in each LN were counted by determining the absolute numbers of lymphocytes and the percentage of CFSE + (any intensity) cells in the LNs.
